More difficult to notice and poorly understood, lobular breast cancer is finally coming under the spotlight but it's not as ...

After surviving brain surgery, I found clarity, strength, and unexpected joy; facing my fears became the turning point, not ...

Advance could usher in new era of research for schizophrenia, autism, Alzheimer's, and other neurological diseases ...

University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients ...

Recent discoveries of how the brain works have shifted focus to brain networks, offering potential new hope for people ...

Global demand for digital biopsy is on the rise, fueled by the growing prevalence of cancers such as breast, brain, melanoma, squamous cell carcinoma, and basal cell carcinoma. The shift toward ...

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

Interdisciplinary GU Cancer Forum 2025, urothelial carcinoma, Metastatic Urothelial Carcinoma, enfortumab vedotin, advanced urothelial carcinoma when enfortumab vedotin, Optimal Sequence of Treatment ...

Endocrine disruption during pregnancy and genetic drivers of bone disease were among the topics experts from UC San Francisco presented at the annual meeting of the Endocrine Society — ENDO 2025 — in ...

Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago.

Hepatitis and fatty liver disease, major causes of chronic liver injury, often present with subtle, easily overlooked ...

A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...